We have extensive experience in the analytics of dry powder inhalers (DPIs), metered-dose inhalers (MDIs) and nebulisers. When the analytics of inhalation drug products must be performed in extreme conditions, our enclosure system allows regulating the surrounding conditions in the temperature range of 17 to 35 °C and relative humidity in the range of 17 to 85 % RH
Our service portfolio includes, among others, the following analytical techniques for inhalation drug products:
- Determination of aerodynamic particle size with the following equipment:
- Next generation Impactor (NGI)
- Multi-Stage Liquid Impinger (MSLI)
- Determination of delivered dose uniformity
Inhalation Analytics is our core competence
